NasdaqGS - Nasdaq Real Time Price USD
Neogen Corporation (NEOG)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 6:49 PM EST
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Total Revenue
912,199.00
924,222.00
822,447.00
527,159.00
468,459.00
Cost of Revenue
460,134.00
460,322.00
416,492.00
284,146.00
253,403.00
Gross Profit
452,065.00
463,900.00
405,955.00
243,013.00
215,056.00
Operating Expense
410,280.00
405,237.00
368,440.00
184,395.00
140,887.00
Operating Income
41,785.00
58,663.00
37,515.00
58,618.00
74,169.00
Net Non Operating Interest Income Expense
-67,988.00
-67,032.00
-52,795.00
1,267.00
1,614.00
Other Income Expense
-5,374.00
-5,936.00
-6,762.00
322.00
-515.00
Pretax Income
-31,577.00
-14,305.00
-22,042.00
60,207.00
75,268.00
Tax Provision
-8,044.00
-4,884.00
828.00
11,900.00
14,386.00
Net Income Common Stockholders
-23,533.00
-9,421.00
-22,870.00
48,307.00
60,882.00
Diluted NI Available to Com Stockholders
-23,533.00
-9,421.00
-22,870.00
48,307.00
60,882.00
Basic EPS
-0.11
-0.04
-0.12
0.45
0.57
Diluted EPS
-0.11
-0.04
-0.12
0.45
0.57
Basic Average Shares
216,578.44
216,481.88
188,880.84
107,801.09
107,468.30
Diluted Average Shares
216,578.44
216,481.88
188,880.84
108,020.00
107,468.30
Total Operating Income as Reported
41,785.00
58,663.00
37,515.00
58,618.00
74,169.00
Total Expenses
870,414.00
865,559.00
784,932.00
468,541.00
394,290.00
Net Income from Continuing & Discontinued Operation
-23,533.00
-9,421.00
-22,870.00
48,307.00
60,882.00
Normalized Income
-23,533.00
-9,421.00
-22,870.00
48,307.00
60,882.00
Interest Income
5,565.00
6,362.00
3,166.00
1,339.00
1,692.00
Interest Expense
73,553.00
73,394.00
55,961.00
72.00
78.00
Net Interest Income
-67,988.00
-67,032.00
-52,795.00
1,267.00
1,614.00
EBIT
41,976.00
59,089.00
33,919.00
60,279.00
75,346.00
EBITDA
164,269.00
180,316.00
124,393.00
84,411.00
96,387.00
Reconciled Cost of Revenue
460,134.00
460,322.00
416,492.00
284,146.00
253,403.00
Reconciled Depreciation
122,293.00
121,227.00
90,474.00
24,132.00
21,041.00
Net Income from Continuing Operation Net Minority Interest
-23,533.00
-9,421.00
-22,870.00
48,307.00
60,882.00
Normalized EBITDA
164,269.00
180,316.00
124,393.00
84,411.00
96,387.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
5/31/2021 - 8/23/1989
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SHC Sotera Health Company
14.31
-4.54%
MYGN Myriad Genetics, Inc.
15.25
-2.74%
QGEN Qiagen N.V.
41.27
-1.95%
NEO NeoGenomics, Inc.
15.04
-4.75%
VCYT Veracyte, Inc.
35.94
-2.97%
BIAF bioAffinity Technologies, Inc.
1.3100
-1.50%
CRL Charles River Laboratories International, Inc.
187.74
-4.65%
GRAL GRAIL, Inc.
14.80
-6.39%
TWST Twist Bioscience Corporation
36.89
-5.31%
MTD Mettler-Toledo International Inc.
1,179.58
-4.70%